Antitcoagulant and antiplatelet activities of scolymoside
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. Here, the anticoagulant effects of scolymoside, an active compound in C. subternata, were examined by monitoring activated partial thromboplastin time (aPTT), prothrombin time (PT), and the activities of thrombin and activated factor X (FXa). The effects of scolymoside on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in tumor necrosis factor (TNF)-α-activated human endothelial cells. Treatment with scolymoside resulted in prolonged aPTT and PT and the inhibition of thrombin and FXa activities and production. In addition, scolymoside inhibited thrombin-catalyzed fibrin polymerization and platelet aggregation. Scolymoside also elicited anticoagulant effects in mice, including a significant reduction in the PAI-1 to t-PA ratio. Collectively, these findings indicate that scolymoside possesses anticoagulant activities and could be developed as a novel anticoagulant.
Abstract
Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. Here, the anticoagulant effects of scolymoside, an active compound in C. subternata, were examined by monitoring activated partial thromboplastin time (aPTT), prothrombin time (PT), and the activities of thrombin and activated factor X (FXa). The effects of scolymoside on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in tumor necrosis factor (TNF)-α-activated human endothelial cells. Treatment with scolymoside resulted in prolonged aPTT and PT and the inhibition of thrombin and FXa activities and production. In addition, scolymoside inhibited thrombin-catalyzed fibrin polymerization and platelet aggregation. Scolymoside also elicited anticoagulant effects in mice, including a significant reduction in the PAI-1 to t-PA ratio. Collectively, these findings indicate that scolymoside possesses anticoagulant activities and could be developed as a novel anticoagulant.
참고문헌 (32)
- Prior RL, "Antioxidant capacity and polyphenolic components of teas: implications for altering in vivo antioxidant status", Proc Soc Exp Biol Med, 220, pp.255~261 (1999)
- Warren CP, "Antioxidant effects of herbs", Lancet, 353, pp.676~ (1999)
- Joubert E, "Honeybush (Cyclopia spp.): From local cottage industry to global markets - The catalytic and supporting role of research", S A J Bot, 77, pp.889~907 (2011)
- Sanchez GM, "Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice", Pharmacol Res, 42, pp.565~573 (2000)
- Leiro JM, "In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes", Biochem Pharmacol, 65, pp.1361~1371 (2003)
- Pardo Andreu GL, "Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats", Eur J Pharmacol, 635, pp.124~128 (2010)
- Kazuno S, "Mass spectrometric identification and quantification of glycosyl flavonoids, including dihydrochalcones with neutral loss scan mode", Anal Biochem, 347, pp.182~192 (2005)
- Palomo I, "Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.)", Exp Ther Med, 3, pp.577~584 (2012)
- Roberfroid MB, "Inulin-type fructans: functional food ingredients", J Nutr, 137, pp.2493~2502 (2007)
- Hasler CM, "Functional foods and cardiovascular disease", Curr Atheroscler Rep, 2, pp.467~475 (2000)
- Philip-Joet F, "Fibrinolytic and inflammatory processes in pleural effusions", Eur Respir J, 8, pp.1352~1356 (1995)
- Schleef RR, "Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor", J Biol Chem, 263, pp.5797~5803 (1988)
- Hamaguchi E, "Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase-and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells", J Pharmacol Exp Ther, 307, pp.987~994 (2003)
- Davie EW, "Biochemical and molecular aspects of the coagulation cascade", Thromb Haemost, 74, pp.1~6 (1995)
- Davie EW, "The coagulation cascade: initiation, maintenance, and regulation", Biochemistry, 30, pp.10363~10370 (1991)
- Quinn C, "A guide for diagnosis of patients with arterial and venous thrombosis", Clin Lab Sci, 13, pp.229~238 (2000)
- Lopez S, "Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells", Atherosclerosis, 152, pp.359~366 (2000)
- Lee KH, "Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine", Public Health Nutr, 3, pp.515~522 (2000)
- Despotis GJ, "Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques", Anesthesiology, 91, pp.1122~1151 (1999)
- Jauch EC, "Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2013, pp.44, 870~947
- Wells PS, "Treatment of venous thromboembolism", JAMA, 311, pp.717~728 (2014)
- Hirsh J, "Heparin : mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety", Chest, 108, pp.258~275 (1995)
- Pereira MS, "Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans?", Glycobiology, 12, pp.573~580 (2002)
- 이원화, "Anticoagulant activities of piperlonguminine in vitro and in vivo", BMB Reports, 46(10), pp.484~489 (2013), 생화학분자생물학회
- 구세광, "Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo", BMB Reports, 47(7), pp.376~381 (2014), 생화학분자생물학회
- 구세광, "Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa", FXa, 2014, pp.37(11), 1454~1463[DOI]
- Sun Young Kim, "PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation", BMB Reports, 44(2), pp.140~145 (2011), 생화학분자생물학회
- Nowak P, "Different vulnerability of fibrinogen subunits to oxidative", nitrative modifications induced by peroxynitrite: functional consequences, 2007, pp.121, 163~174
- Bae JS, "Transforming Growth Factor beta-induced Protein Promotes Severe Vascular Inflammatory Responses", Am J Respir Crit Care Med, 189, pp.779~786 (2014)
- 구세광, "Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo", BMB Reports, 47(6), pp.336~341 (2014), 생화학분자생물학회
- Bae JS, "Antithrombotic and profibrinolytic activities of phloroglucinol", Food Chem Toxicol, 49, pp.1572~1577 (2011)
- Kim TH, "Antithrombotic and profibrinolytic activities of eckol and dieckol", J Cell Biochem, 113, pp.2877~2883 (2012)